Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease

References

• Casanova J-LL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581–620.
   PubMed Web of Science ®Google Scholar
• Bustamante J, Boisson-Dupuis SSS, Abel L, et al. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFNgamma immunity. Semin Immunol. 2014;26:454–470.
   PubMed Web of Science ®Google Scholar
• Picard C, Bobby Gaspar H, Al-Herz W, et al. International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38:96–128.
   PubMed Web of Science ®Google Scholar
• Mishra A, Akhtar S, Jagannath C, et al. Pattern recognition receptors and coordinated cellular pathways involved in tuberculosis immunopathogenesis: emerging concepts and perspectives. Mol Immunol. 2017;87:240–248.
   PubMed Web of Science ®Google Scholar
• Alsina L, Israelsson E, Altman MC, et al. A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4. Nat Immunol. 2014;15:1134–1142.
   PubMed Web of Science ®Google Scholar
• D’Cunha J, Ramanujam S, Wagner RJ, et al. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol. 1996;157:4100–4108.
   PubMed Web of Science ®Google Scholar
• Bogunovic D, Byun M, Durfee LA, et al. Mycobacterial disease and impaired IFN-immunity in humans with inherited ISG15 deficiency. Science. 2012;337:1684–1688.
   PubMed Web of Science ®Google Scholar
• Cottle LE. Mendelian susceptibility to mycobacterial disease. Clin Genet. 2011;79:17–22.
   PubMed Web of Science ®Google Scholar
• Ramirez-Alejo N, Santos-Argumedo L. Innate defects of the IL-12/IFN-γ axis in susceptibility to infections by mycobacteria and salmonella. J Interf Cytokine Res. 2014;34:307–317.
   PubMed Web of Science ®Google Scholar
• Torrado E, Cooper AM. Cytokines in the balance of protection and pathology during mycobacterial infections. In: Divangahi M, editor. The new paradigm of immunity to tuberculosis. New York (NY): Springer New York; 2013. p. 121–140.
   Google Scholar
• Zundler S, Neurath MF. Interleukin-12: functional activities and implications for disease. Cytokine Growth Factor Rev. 2015;26:559–568.
   PubMed Web of Science ®Google Scholar
• Watford WT, Hissong BD, Bream JH, et al. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev. 2004;202:139–156.
   PubMed Web of Science ®Google Scholar
• Bogunovic D, Boisson-Dupuis S, Casanova J-L. ISG15: leading a double life as a secreted molecule. Exp Mol Med. 2013;45:e18.
   PubMed Web of Science ®Google Scholar
• Majoros A, Platanitis E, Kernbauer-Hölzl E, et al. Canonical and non-canonical aspects of JAK–STAT signaling: lessons from interferons for cytokine responses. Front Immunol. 2017;8:29.
   PubMed Web of Science ®Google Scholar
• Stark GR. How cells respond to interferons revisited: from early history to current complexity. Cytokine Growth Factor Rev. 2007;18:419–423.
   PubMed Web of Science ®Google Scholar
• Mimouni J. Our experiences in three years of BCG vaccination at the center of the O.P.H.S. at Constantine; study of observed cases (25 cases of complications from BCG vaccination). Alger Med. 1951;55:1138–1147.
   PubMedGoogle Scholar
• Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med. 1996;335:1956–1961.
   PubMed Web of Science ®Google Scholar
• Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;335:1941–1949.
   PubMed Web of Science ®Google Scholar
• Feinberg J, Fieschi C, Doffinger R, et al. Bacillus Calmette Guérin triggers the IL-12/IFN-γ axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol. 2004;34:3276–3284.
   PubMed Web of Science ®Google Scholar
• van de Vosse E, Haverkamp MH, Ramirez-Alejo N, et al. IL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database. Hum Mutat. 2013;34:1329–1339.
   PubMed Web of Science ®Google Scholar
• de Beaucoudrey L, Samarina A, Bustamante J, et al. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore). 2010;89:381–402.
   PubMed Web of Science ®Google Scholar
• Altare F, Lammas D, Revy P, et al. Rapid publication inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and salmonella enteritidis disseminated infection. J Clin Invest. 1998;102:2035–2040.
   PubMed Web of Science ®Google Scholar
• Prando C, Samarina A, Bustamante J, et al. Inherited IL-12p40 deficiency. Medicine (Baltimore). 2013;92:109–122.
   PubMed Web of Science ®Google Scholar
• Zhang X, Bogunovic D, Payelle-Brogard B, et al. Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. Nature. 2015;517:89–93.
   PubMed Web of Science ®Google Scholar
• Bustamante J, Picard C, Boisson-Dupuis S, et al. Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases. Ann NY Acad Sci. 2011;1246:92–101.
   PubMed Web of Science ®Google Scholar
• Hambleton S, Salem S, Bustamante J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med. 2011;365:127–138.
   PubMed Web of Science ®Google Scholar
• Kreins AY, Ciancanelli MJ, Okada S, et al. Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med. 2015;212:1641–1662.
   PubMed Web of Science ®Google Scholar
• Jouanguy E, Dupuis S, Pallier A, et al. In a novel form of IFN-γ receptor 1 deficiency, cell surface receptors fail to bind IFN-γ. J Clin Invest. 2000;105:1429–1436.
   PubMed Web of Science ®Google Scholar
• Dorman SE, Picard C, Lammas D, et al. Clinical features of dominant and recessive interferon γ receptor 1 deficiencies. Lancet. 2004;364:2113–2121.
   PubMed Web of Science ®Google Scholar
• Sologuren I, Boisson-Dupuis S, Pestano J, et al. Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds. Hum Mol Genet. 2011;20:1509–1523.
   PubMed Web of Science ®Google Scholar
• Jouanguy E, Lamhamedi-Cherradi S, Lammas D, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet. 1999;21:370–378.
   PubMed Web of Science ®Google Scholar
• Rosenzweig SD, Schwartz OM, Brown MR, et al. Characterization of a dipeptide motif regulating IFN-receptor 2 plasma membrane accumulation and IFN-responsiveness. J Immunol. 2004;173:3991–3999.
   PubMed Web of Science ®Google Scholar
• Moncada-Velez M, Martinez-Barricarte R, Bogunovic D, et al. Partial IFN-R2 deficiency is due to protein misfolding and can be rescued by inhibitors of glycosylation. Blood. 2013;122:2390–2401.
   PubMed Web of Science ®Google Scholar
• Chapgier A, Boisson-Dupuis S, Jouanguy E, et al. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet. 2006;2:e131.
   PubMed Web of Science ®Google Scholar
• Dupuis S. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science. 2001;293:300–303.
   PubMed Web of Science ®Google Scholar
• Hirata O, Okada S, Tsumura M, et al. Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis. Haematologica. 2013;98:1641–1649.
   PubMed Web of Science ®Google Scholar
• Bustamante J, Arias AA, Vogt G, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 2011;12:213–221.
   PubMed Web of Science ®Google Scholar
• Bustamante J, Picard C, Fieschi C, et al. A novel X-linked recessive form of Mendelian susceptibility to mycobacterial disease. J Med Genet. 2006;44:e65.
   Web of Science ®Google Scholar
• Filipe-Santos O, Bustamante J, Chapgier A, et al. Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features. Semin Immunol. 2006;18:347–361.
   PubMed Web of Science ®Google Scholar
• Olbrich P, Martínez-Saavedra MT, Perez-Hurtado JM, et al. Diagnostic and therapeutic challenges in a child with complete interferon-γ receptor 1 deficiency. Pediatr Blood Cancer. 2015;62:2036–2039.
   PubMed Web of Science ®Google Scholar
• Zwerling A, Behr MA, Verma A, et al. The BCG world atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8:e1001012.
   PubMed Web of Science ®Google Scholar
• Boisson-Dupuis S, Bustamante J, El-Baghdadi J, et al. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev. 2015;264:103–120.
   PubMed Web of Science ®Google Scholar
• Boisson-Dupuis S, El Baghdadi J, Parvaneh N, et al. IL-12Rbeta1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One. 2011;6:e18524.
   PubMed Web of Science ®Google Scholar
• Caragol I, Raspall M, Fieschi C, et al. Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency. Clin Infect Dis. 2003;37:302–306.
   PubMed Web of Science ®Google Scholar
• Jouanguy E, Lamhamedi-Cherradi S, Altare F, et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest. 1997;100:2658–2664.
   PubMed Web of Science ®Google Scholar
• Parvaneh N, Barlogis V, Alborzi A, et al. Visceral leishmaniasis in two patients with IL-12p40 and IL-12Rβ1 deficiencies. Pediatr Blood Cancer. 2017;64:e26362.
   Web of Science ®Google Scholar
• Obinata K, Lee T, Niizuma T, et al. Two cases of partial dominant interferon-γ receptor 1 deficiency that presented with different clinical courses of bacille Calmette-Guérin multiple osteomyelitis. J Infect Chemother. 2013;19:757–760.
   PubMed Web of Science ®Google Scholar
• Villella A, Picard C, Jouanguy E, et al. Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation. Pediatrics. 2001;107:E47.
   PubMed Web of Science ®Google Scholar
• Jirapongsananuruk O, Luangwedchakarn V, Niemela JE, et al. Cryptococcal osteomyelitis in a child with a novel compound mutation of the IL12RB1 gene. Asian Pacific J Allergy Immunol. 2012;30:79–82.
   PubMed Web of Science ®Google Scholar
• Boudjemaa S, Dainese L, Héritier S, et al. Disseminated BCG osteomyelitis related to STAT 1 gene deficiency mimicking a metastatic neuroblastoma. Pediatr Dev Pathol. 2017;3:255–261.
   Google Scholar
• Shamriz O, Engelhard D, Rajs AP, et al. Mycobacterium szulgai chronic multifocal osteomyelitis in an adolescent with inherited STAT1 deficiency. Pediatr Infect Dis J. 2013;32:1345–1347.
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Nomura A, Kusuhara K, et al. Genetic basis of patients with bacille Calmette-Guerin osteomyelitis in Japan: identification of dominant partial interferon-gamma receptor 1 deficiency as a predominant type. J Infect Dis. 2002;185:706–709.
   PubMed Web of Science ®Google Scholar
• Arend SM, Janssen R, Gosen JJ, et al. Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferon-gamma receptor. Neth J Med. 2001;59:140–151.
   PubMed Web of Science ®Google Scholar
• Conti F, Lugo-Reyes SO, Blancas Galicia L, et al. Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases. J Allergy Clin Immunol. 2016;138:241–248.e3.
   PubMed Web of Science ®Google Scholar
• Picard C, Casanova JL. Inherited disorders of cytokines. Curr Opin Pediatr. 2004;16:648–658.
   PubMed Web of Science ®Google Scholar
• Orange JS, Levy O, Brodeur SR, et al. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J Allergy Clin Immunol. 2004;114:650–656.
   PubMed Web of Science ®Google Scholar
• Orange JS, Brodeur SR, Jain A, et al. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest. 2002;109:1501–1509.
   PubMed Web of Science ®Google Scholar
• Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123:809–821.
   PubMed Web of Science ®Google Scholar
• Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118:2653–2655.
   PubMed Web of Science ®Google Scholar
• Mace EM, Hsu AP, Monaco-Shawver L, et al. Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56bright subset. Blood. 2013;121:2669–2677.
   PubMed Web of Science ®Google Scholar
• Vairo D, Tassone L, Tabellini G, et al. Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation. Blood. 2011;118:1806–1817.
   PubMed Web of Science ®Google Scholar
• Kong X-F, Ciancanelli M, Al-Hajjar S, et al. A novel form of human STAT1 deficiency impairing early but not late responses to interferons. Blood. 2010;116:5895–5906.
   PubMed Web of Science ®Google Scholar
• Chapgier A, Kong XF, Boisson-Dupuis S, et al. A partial form of recessive STAT1 deficiency in humans. J Clin Invest. 2009;119:1502–1514.
   PubMed Web of Science ®Google Scholar
• Chapgier A, Wynn RF, Jouanguy E, et al. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol. 2006;176:5078–5083.
   PubMed Web of Science ®Google Scholar
• Dupuis S, Jouanguy E, Al-Hajjar S, et al. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet. 2003;33:388–391.
   PubMed Web of Science ®Google Scholar
• Moens L, Frans G, Bosch B, et al. Successful hematopoietic stem cell transplantation for myelofibrosis in an adult with warts-hypogammaglobulinemia-immunodeficiency-myelokathexis syndrome. J Allergy Clin Immunol. 2016;138:1485–1489.e2.
   PubMed Web of Science ®Google Scholar
• Hambleton S, Goodbourn S, Young DF, et al. STAT2 deficiency and susceptibility to viral illness in humans. Proc Natl Acad Sci USA. 2013;110:3053–3058.
   PubMed Web of Science ®Google Scholar
• Eletto D, Burns SO, Angulo I, et al. Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection. Nat Commun. 2016;7:13992.
   PubMed Web of Science ®Google Scholar
• Okada S, Markle JG, Deenick EK, et al. Immunodeficiencies. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science. 2015;349:606–613.
   PubMed Web of Science ®Google Scholar
• Brode SK, Jamieson FB, Ng R, et al. Increased risk of mycobacterial infections associated with anti-rheumatic medications. Thorax. 2015;70:677–682.
   PubMed Web of Science ®Google Scholar
• Lake MA, Ambrose LR, Lipman MCI, et al. ‘“Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med. 2016;14:54.
   PubMed Web of Science ®Google Scholar
• Cisneros JR, Murray KM. Corticosteroids in tuberculosis. Ann Pharmacother. 1996;30:1298–1303.
   PubMed Web of Science ®Google Scholar
• Orme IM, Ordway DJ. Host response to nontuberculous mycobacterial infections of current clinical importance. Infect Immun. 2014;82:3516–3522.
   PubMed Web of Science ®Google Scholar
• Thaker H, Neilly IJ, Saunders PG, et al. Remember mycobacterial disease in hairy cell leukaemia (HCL). J Infect. 2001;42:213–214.
   PubMed Web of Science ®Google Scholar
• Kraut EH. Clinical manifestations and infectious complications of hairy-cell leukaemia. Best Pract Res Clin Haematol. 2003;16:33–40.
   PubMed Web of Science ®Google Scholar
• Netea MG, Hoitink O, Kullberg BJ, et al. Defective interferon-gamma production in patients with hairy cell leukaemia. Neth J Med. 2008;66:340–343.
   PubMed Web of Science ®Google Scholar
• Arlotta A, Cefalo MG, Maurizi P, et al. Critical pulmonary infection due to nontuberculous mycobacterium in pediatric leukemia: report of a difficult diagnosis and review of pediatric series. J Pediatr Hematol Oncol. 2014;36:66–70.
   PubMed Web of Science ®Google Scholar
• Kampmann B, Hemingway C, Stephens A, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-γ. J Clin Invest. 2005;115:2480–2488.
   PubMed Web of Science ®Google Scholar
• Lee W-I, Huang J-L, Wu T-S, et al. Patients with inhibitory and neutralizing auto-antibodies to interferon-γ resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette–Guerin (BCG)-induced diseases. Immunobiology. 2013;218:762–771.
   PubMed Web of Science ®Google Scholar
• Hanitsch LG, Löbel M, Müller-Redetzky H, et al. Late-onset disseminated Mycobacterium avium intracellulare Complex Infection (MAC), cerebral toxoplasmosis and salmonella sepsis in a German Caucasian patient with unusual anti-interferon-Gamma IgG1 autoantibodies. J Clin Immunol. 2015;35:361–365.
   PubMed Web of Science ®Google Scholar
• Wu U-I, Chuang Y-C, Sheng W-H, et al. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection. Clin Microbiol Infect. 2018;24:159–165.
   PubMed Web of Science ®Google Scholar
• Fieschi C, Dupuis S, Picard C, et al. High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics. 2001;107:E48.
   PubMed Web of Science ®Google Scholar
• Martínez-Barricarte R, Megged O, Stepensky P, et al. Mycobacterium simiae infection in two unrelated patients with different forms of inherited IFN-γR2 deficiency. J Clin Immunol. 2014;34:904–909.
   PubMed Web of Science ®Google Scholar
• Rottman M, Soudais C, Vogt G, et al. IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts. PLoS Med. 2008;5:e26.
   PubMed Web of Science ®Google Scholar
• Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest. 1998;101:2364–2369.
   PubMed Web of Science ®Google Scholar
• Puel A, Reichenbach J, Bustamante J, et al. The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation. Am J Hum Genet. 2006;78:691–701.
   PubMed Web of Science ®Google Scholar
• Vogt G, Chapgier A, Yang K, et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet. 2005;37:692–700.
   PubMed Web of Science ®Google Scholar
• Rosenzweig SD, Dorman SE, Uzel G, et al. A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol. 2004;173:4000–4008.
   PubMed Web of Science ®Google Scholar
• Holland SM, Dorman SE, Kwon A, et al. Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency. J Infect Dis. 1998;178:1095–1104.
   PubMed Web of Science ®Google Scholar
• Noordzij JG, Hartwig NG, Verreck FA, et al. Two patients with complete defects in interferon gamma receptor-dependent signaling. J Clin Immunol. 2007;27:490–496.
   PubMed Web of Science ®Google Scholar
• Prando C, Boisson-Dupuis S, Grant AV, et al. Paternal uniparental isodisomy of chromosome 6 causing a complex syndrome including complete IFN-γ receptor 1 deficiency. Am J Med Genet. 2010;152A:622–629.
   PubMed Web of Science ®Google Scholar
• Kong X-FF, Vogt G, Itan Y, et al. Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease. Hum Mol Genet. 2013;22:769–781.
   PubMed Web of Science ®Google Scholar
• Tsumura M, Okada S, Sakai H, et al. Dominant-negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease. Hum Mutat. 2012;33:1377–1387.
   PubMed Web of Science ®Google Scholar
• Janssen R, Van Wengen A, Verhard E, et al. Divergent role for TNF-alpha in IFN-gamma-induced killing of Toxoplasma gondii and Salmonella typhimurium contributes to selective susceptibility of patients with partial IFN-gamma receptor 1 deficiency. J Immunol. 2002;169:3900–3907.
   PubMed Web of Science ®Google Scholar
• Okada S, Ishikawa N, Shirao K, et al. The novel IFNGR1 mutation 774del4 produces a truncated form of interferon-gamma receptor 1 and has a dominant-negative effect on interferon-gamma signal transduction. J Med Genet. 2007;44:485–491.
   PubMed Web of Science ®Google Scholar
• Takeda K, Kawai T, Nakazawa Y, et al. Augmentation of antitubercular therapy with IFNγ in a patient with dominant partial IFNγ receptor 1 deficiency. Clin Immunol. 2014;151:25–28.
   PubMed Web of Science ®Google Scholar
• Allende LM, Lopez-Goyanes A, Paz-Artal E, et al. A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency. Clin Diagn Lab Immunol. 2001;8:133–137.
   PubMedGoogle Scholar
• Kilic SS, van Wengen A, de Paus RA, et al. Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-γR2 deficiency. J Infect. 2012;65:568–572.
   PubMed Web of Science ®Google Scholar
• Filipe-Santos O, Bustamante J, Haverkamp MH, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med. 2006;203:1745–1759.
   PubMed Web of Science ®Google Scholar
• Pedraza-Sánchez S, Herrera-Barrios MT, Aldana-Vergara R, et al. Bacille Calmette–Guérin infection and disease with fatal outcome associated with a point mutation in the interleukin-12/interleukin-23 receptor beta-1 chain in two Mexican families. Int J Infect Dis. 2010;14:e256–e260.
   PubMed Web of Science ®Google Scholar
• Ehlayel M, de Beaucoudrey L, Fike F, et al. Simultaneous presentation of 2 rare hereditary immunodeficiencies: IL-12 receptor beta1 deficiency and ataxia-telangiectasia. J Allergy Clin Immunol. 2008;122:1217–1219.
   PubMed Web of Science ®Google Scholar
• Fieschi C. A novel form of complete IL-12/IL-23 receptor 1 deficiency with cell surface-expressed nonfunctional receptors. Blood. 2004;104:2095–2101.
   PubMed Web of Science ®Google Scholar
• de Souza TL, de Souza Campos Fernandes RC, da Silva JA, et al. Microbial disease spectrum linked to a novel IL-12Rβ1 N-terminal signal peptide stop-gain homozygous mutation with paradoxical receptor cell-surface expression. Front Microbiol. 2017;8:1–10.
   PubMed Web of Science ®Google Scholar
• Casanova JL, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity. 2012;36:515–528.
   PubMed Web of Science ®Google Scholar
• Qu H-Q, Fisher-Hoch SP, McCormick JB. Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases. Int J Infect Dis. 2011;15:e305–e313.
   PubMed Web of Science ®Google Scholar
• Sampaio EP, Bax HI, Hsu AP, et al. A novel STAT1 mutation associated with disseminated mycobacterial disease. J Clin Immunol. 2012;32:681–689.
   PubMed Web of Science ®Google Scholar
• Kong X-FF, Vogt G, Chapgier A, et al. A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon. Hum Mol Genet. 2010;19:434–444.
   PubMed Web of Science ®Google Scholar
• Storgaard M, Varming K, Herlin T, et al. Novel mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infections. Scand J Immunol. 2006;64:137–139.
   PubMed Web of Science ®Google Scholar
• de Paus RA, Kilic SS, van Dissel JT, et al. Effect of amino acid substitutions in the human IFN-γR2 on IFN-γ responsiveness. Genes Immun. 2011;12:136–144.
   PubMed Web of Science ®Google Scholar
• Kagawa R, Fujiki R, Tsumura M, et al. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants. J Allergy Clin Immunol. 2017;140:232–241.
   PubMed Web of Science ®Google Scholar
• Uzel G, Frucht DM, Fleisher TA, et al. Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin Immunol. 2001;100:270–276.
   PubMed Web of Science ®Google Scholar
• Chi CY, Chu CC, Liu JP, et al. Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121:1357–1366.
   PubMed Web of Science ®Google Scholar
• Patel SY, Ding L, Brown MR, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005;175:4769–4776.
   PubMed Web of Science ®Google Scholar
• Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367:725–734.
   PubMed Web of Science ®Google Scholar
• Conti F, Aragão Filho WC, Prando C, et al. Phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity in patients with inherited IFN-γR1 or IFN-γR2 deficiency. J Allergy Clin Immunol. 2015;135:1393–1395.e1.
   PubMed Web of Science ®Google Scholar
• Meyts I, Bosch B, Bolze A, et al. Exome and genome sequencing for inborn errors of immunity. J Allergy Clin Immunol. 2016;138:957–969.
   PubMed Web of Science ®Google Scholar
• Casanova J-L, Conley ME, Seligman SJ, et al. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J Exp Med. 2014;211:2137–2149.
   PubMed Web of Science ®Google Scholar
• Döffinger R, Jouanguy E, Dupuis S, et al. Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guerin and Mycobacterium abscessus infection. J Infect Dis. 2000;181:379–384.
   PubMed Web of Science ®Google Scholar
• Martínez-Barricarte R, de Jong SJ, Markle J, et al. Transduction of Herpesvirus saimiri-transformed T cells with exogenous genes of interest. In: Current protocols in immunology. Hoboken (NJ): John Wiley & Sons, Inc.; 2016. p. 7.21C.1–7.21C.12.
   Google Scholar
• Smith T. Parasitism and disease. Princeton: Princeton University Press; 1934.
   Google Scholar
• Casanova J-L. Human genetic basis of interindividual variability in the course of infection. Proc Natl Acad Sci. 2015;112:7118–7127.
   PubMed Web of Science ®Google Scholar
• Casanova J-L. Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc Natl Acad Sci USA. 2015;112:7128–7137.
   PubMed Web of Science ®Google Scholar
• Holland SM. Treatment of infections in the patient with Mendelian susceptibility to mycobacterial infection. Microbes Infect. 2000;2:1579–1590.
   PubMed Web of Science ®Google Scholar